4016 Stock Overview
Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Middle East Pharmaceutical Industries Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س145.00 |
| 52 Week High | ر.س197.60 |
| 52 Week Low | ر.س90.20 |
| Beta | 0 |
| 1 Month Change | 1.40% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 36.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4016 | SA Pharmaceuticals | SA Market | |
|---|---|---|---|
| 7D | -1.0% | 4.0% | -0.4% |
| 1Y | n/a | 3.2% | -1.4% |
Return vs Industry: Insufficient data to determine how 4016 performed against the SA Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 4016 performed against the SA Market.
Price Volatility
| 4016 volatility | |
|---|---|
| 4016 Average Weekly Movement | 16.1% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SA Market | 8.2% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 4016's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 4016's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 543 | n/a | www.avalonpharmaceutical.com |
Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic medicines and preparations, including sexual system drugs, diabetes, cardiovascular drugs, anti-infective drugs, anti-parasitic drugs, pain relievers, antiseptics, and women’s and men’s health drugs in the form of creams, rolls, masks, ointments, syrups, lotions, capsules, gels, hand sanitizers, tonics, mouthwashes, soaps, solutions, sprays, scrubs, topical solutions, and tablets.
Middle East Pharmaceutical Industries Company Fundamentals Summary
| 4016 fundamental statistics | |
|---|---|
| Market cap | ر.س2.90b |
| Earnings (TTM) | ر.س65.83m |
| Revenue (TTM) | ر.س338.44m |
44.1x
P/E Ratio8.6x
P/S RatioIs 4016 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4016 income statement (TTM) | |
|---|---|
| Revenue | ر.س338.44m |
| Cost of Revenue | ر.س131.40m |
| Gross Profit | ر.س207.04m |
| Other Expenses | ر.س141.22m |
| Earnings | ر.س65.83m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.29 |
| Gross Margin | 61.18% |
| Net Profit Margin | 19.45% |
| Debt/Equity Ratio | 19.5% |
How did 4016 perform over the long term?
See historical performance and comparison